SlideShare ist ein Scribd-Unternehmen logo
1 von 49
UNIT
IX
PART A
Site-directed
Mutagenesis (SDM)
GEB, Sem VI, B.Sc (H)
Biochemistry Dr. Jayita
Thakur
Michael Smith, a British-born Canadian biochemist won
the 1993 Nobel Prize (with Kary B. Mullis) in
Chemistry for the development of a technique called -
oligonucleotide-based site-directed mutagenesis,
which enabled researchers to introduce specific
mutations into genes and, thus, to the proteins that
they encode.
Site-directed mutagenesis (SDM) is a method to create specific,
targeted changes in double stranded plasmid DNA.
There are many reasons to make specific DNA alterations
(insertions, deletions and substitutions), including:
• To study changes in protein activity that occur as a result of the
DNA manipulation.
• To select or screen for mutations (at the DNA, RNA or protein
level) that have a desired property.
• To introduce or remove restriction endonuclease sites or tags.
Using site-directed mutagenesis,
• scientists have been able to dissect the structure and
function relationships involved in protein plaque
formation in the pathophysiology of Alzheimer disease;
• study the feasibility of gene therapy approaches for
cystic fibrosis, sickle-cell disease, and hemophilia;
• determine the characteristics of protein receptors at
neurotransmitter binding sites and design analogs with
novel pharmaceutical properties;
• examine the viral proteins involved in immunodeficiency
disease;
• and improve the properties of industrial enzymes used
in food science and technology.
STRATEGIES OF DIRECTED MUTAGENESIS
A. Oligonucleotide-Directed Mutagenesis with M13 DNA
B. Oligonucleotide-Directed Mutagenesis with Plasmid DNA
C. PCR based mutagenesis
i. PCR-Amplified Oligonucleotide-Directed
Mutagenesis
ii. Error-Prone PCR
iii. Random Mutagenesis with Degenerate
Oligonucleotide Primers
D. Random Insertion/Deletion Mutagenesis
E. DNA Shuffling
F. Mutant Proteins with Unusual Amino Acids
A. Oligonucleotide-directed
mutagenesis with M13
DNA
Single-stranded bacteriophage M13 (M13 + strand), carrying a cloned gene is taken.
It is annealed with a complementary synthetic oligonucleotide containing one mismatched
base.
With the oligonucleotide as the primer, DNA synthesis is catalyzed by the Klenow fragment
of E. coliDNA polymerase I.
Synthesis continues until the entire strand is copied. The newly synthesized DNA strand is
circularized byT4 DNA ligase.
The ligation reaction mixture is used to transform E. coli.
Both the target DNA with its original sequence and the mutated sequence are present in the
progeny M13 phage.
After the double-stranded form of M13 is isolated, the mutated gene is excised by digestion
with restriction enzymes and then spliced onto an E. coliplasmid expression vector.
For further study, the altered protein is expressed in and purified from the E.
colicells.
As per the diagram we see only 50% of the
M13 viruses are expected to carrying the
mutated form of thetarget.
In practice only around 1% of the plaques
actually contain phage carrying the mutated
gene.
Consequently, the oligonucleotide-directed
mutagenesis method has been modified in
several ways to enrich for the number of
mutant phage plaques that can be obtained.
Modification
Introduce the M13 viral vector carrying the gene that is to
be mutagenized into an E. coli strain that has two
defective enzymes of DNAmetabolism.
dUTPase (dut)
Cells without a
dUTPase have an
functional
elevated
intracellular level of dUTP
,
which in turn causes a few
incorporated into
dUTP residues to be
DNA
during replication instead of
dTTP.
uracil N-glycosylase (ung)
In the absence of functional
uracil N-glycosylase, the
dUTP residues that were
spuriously incorporated into
DNA cannot be removed.
The target DNA is cloned into the double-stranded replicative form of
bacteriophage M13, which is then used to transform a dut ung strain of E.
coli.
The dut mutation causes the intracellular level of dUTP to be elevated; the
high level of nucleotide leads to the incorporation of a few dUTP residues
(U). The ung mutation prevents the removal of any incorporated uracil
residues.
Following in vitro oligonucleotide-directed mutagenesis, the double-
stranded M13 vector with the mutated DNA is introduced into wild-type
E. coli.
The wild-type ung gene product removes any uracil residues from the
parental strand, so a significant portion of the parental strand is degraded.
The mutated strand remains intact because it does not contain uracil. It
serves as a template for DNA replication, thereby enriching the yield of
M13 bacteriophage carrying the mutated gene.
Drawbacks of using the M13DNA for carrying out SDM
• There is a need to subclone a target gene from a plasmid
into M13 and then, after mutagenesis, clone it back into a
plasmid.
• Additional step of transforming enzyme defective E. coli
necessary to enrich the yield.
• Lengthy process involving multiple steps
B. Oligonucleotide-Directed Mutagenesis
with Plasmid DNA
Thetarget DNAis inserted into the multiple cloning
site (MCS)on the vector pALTER.
Plasmid DNAis isolated from E. coli cells and
alkalinedenatured.
Mutagenic
resistance
tetracycline
annealed.
oligonucleotide, the
(Ampr) oligonucleotide,
ampicillin
and the
sensitivity (Tets)oligonucleotide are
The oligonucleotides act as primers for DNA
synthesis by T4 DNA polymerase with the original
strand asthe template.
The gaps between the synthesized pieces of DNA
are sealed by T4DNAligase.
The reaction mixture is used to transform E. coli
host cells, and cells that are Ampr and Tets are
selected.
• With this procedure, about 90% of the selected
transformants have the specified mutation in the target
gene.
• In the remaining transformants, the target gene is
unchanged because the oligonucleotide did not anneal to
the target gene or it was bypassed during DNA synthesis.
• The cells with the specified mutation in the target gene
are identified by DNA hybridization.
• All of the plasmids, host bacterial strains, enzymes,
oligonucleotides (other than the one needed to alter the
target gene), and buffers for this method are sold as a kit,
facilitating its widespread use.
C. PCR based mutagenesis
C. (i)PCR-Amplified Oligonucleotide-
Directed Mutagenesis
• For this method of mutagenesis, no special plasmid vectors are
required; any plasmid up to approximately 10 kb in length is
acceptable.
• For PCR-based mutagenesis point mutations, nucleotide
changes are introduced in the middle of the primer sequence.
• To create deletion mutations, primers must border the region of
target DNA to be deleted on both sides and be perfectly
matched to their annealing (or template) sequences.
• To create mutations with long insertions, a stretch of
mismatched nucleotides is added to the 5′ end of one or both
primers, while for mutations with short insertions, a stretch of
nucleotides is designed in the middle of one of the primers.
Overview of the basic methodology to introduce point mutations, insertions, or
deletions into DNAcloned into aplasmid.
In all of these procedures, the only absolute requirementsare
that:
(1)the nucleotide sequence of the target DNA must be known.
(2)the 5′ends of the primers must be phosphorylated.
Following PCR amplification, the linear DNA is circularized by
ligation with T4 DNA ligase.
The circularized plasmid DNA is then used to transform E. coli
by any standard procedure.
This protocol yields a very high frequency of plasmids with the
desired mutation. The screening three or four clones by
sequencing the target DNA should be sufficient to find the
desired
In summary, this procedure introduces a specified mutation
(point, insertion, or deletion) into a cloned gene without the
need to insert the cloned gene into bacteriophage M13; to use
enrichment procedures, such as the dut ung system; or to
subclone the mutated gene from M13 onto an expression
plasmid vector.
Given its simplicity and effectiveness, this procedure has come
to be widely used.
C. (ii) Error-Prone PCR
This is a very powerful method for random mutagenesis useful for
the construction of a library of mutants.
With DNA up to 10 kb in size, it is possible to vary the number of
alterations per gene from about 1 to about 20 by modifying the
DNA template concentration.
When error-prone PCR is performed using Taq DNA polymerase,
which lacks proofreading activity, the error rate may be increased-
A. by adding Mn2+, by increasing the concentration of Mg2+
B. by adding unequal amounts of the four deoxynucleoside
triphosphates to the reaction buffer.
C. by using other temperature-stable DNA polymerases in the
absence of Mn2+ and with balanced amounts of the four
deoxynucleoside triphosphates.
• Following error-prone PCR, the randomly mutagenized
DNA is cloned into expression vectors and screened for
altered or improved protein activity.
• The DNA from those clones that encode the desired
activity is isolated and sequenced so that the relevant
changes to the target DNA may be elaborated.
• Error-prone PCR has been used to create enzymes with
improved solvent and temperature stability and with
enhanced specific activity.
Drawback
Since errors are typically introduced into DNA at no more
than one or two per 1,000 nucleotides, only single
nucleotides are replaced within a triplet codon, yielding
only a limited number of amino acid changes.
C. (iii) Random Mutagenesis with Degenerate
Oligonucleotide Primers
Investigators seldom know which specific nucleotide
changes need to be introduced into a cloned gene to
modify the properties of the targetprotein.
Consequently, they must use methods that generate all
the possible amino acid changes at one particular site.
For example, oligonucleotide primers can be synthesized
with any of the four nucleotides at defined positions.
This pattern of sequence degeneracy is generally
achieved by programming an automated DNA synthesis
reaction to add a low level (usually a few percent) of each
of the three alternative nucleotides each time a particular
nucleotide is added to the chain.
In this way, the oligonucleotide primer preparation contains a
heterogeneous set of DNA sequences that will generate a series of
mutations that are clustered in a defined portion of the target gene.
A target gene is inserted into a plasmid
between two unique restriction endonuclease
sites.
The left and right portions of the target
DNA are amplified separately by PCR.
The amplified fragments are purified,
denatured to make them single stranded, and
then reannealed.
Complementary regions of overlap are
formed between complementary
producing oligonucleotides. The
mutation
single-
stranded regions are made double stranded
with DNA polymerase, and then the entire
fragment is amplified by PCR.
The resultant product is digested with
restriction endonucleases A and B and then
cloned into a vector that has been digested
with the same enzymes.
A mutation producing
oligonucleotide is shown as a line
with three spikes; each spike
denotes a position that contains a
nucleotide that is not found in the
native gene.
This approach has two advantages.
(1) Detailed information regarding the roles of particular
amino acid residues in the functioning of the protein
is not required.
(2) Unexpected mutants encoding proteins with a range
of interesting and useful properties may be generated
because the introduced changes are not limited to one
amino acid.
D. Random Insertion/Deletion
Mutagenesis
As an alternative to error-prone PCR, researchers have
developed the technique of random insertion/deletion
mutagenesis.
With this approach, it is possible to delete a small number of
nucleotides at random positions along the gene and, at the
same time, insert either specific or random sequences into
that position.
1. An isolated gene fragment with different restriction endonuclease
sites at each end is ligated at one end to a short nonphosphorylated
linker that leaves a small gap in the DNA. The gap is a consequence of
the fact that the 5′ nucleotide from the linker is not phosphorylated
and therefore cannot be ligated to an adjacent 3′-OHgroup.
2. After restriction enzyme digestion that creates compatible sticky
ends, the gene fragment is cyclized with T4 DNA ligase to create a
circular double-stranded gene fragment with a nick in the antisense
strand.
3. The nicked strand is degraded by digestion with the enzyme T4 DNA
polymerase (which hasexonuclease activity).
4. The single-stranded DNA is randomly cleaved at single positions by
treating it with a cerium(IV)–ethylenediaminetetraacetic acid (EDTA)
complex.
5.The linear single-stranded DNAs are ligated to a linker (containing
several additional nucleotides selected for insertion at one end), and
the entire mutagenesis library is PCRamplified.
6. Thelinkers are removed by restriction enzyme digestion.
7.The constructs are made blunt ended by filling in the single stranded
overhangs using the Klenow fragment of E. coli DNApolymerase I and
then cyclized again by T4DNAligase.
8.Theamplified products are digested with appropriate restriction
enzymes, cloned into aplasmid vector, and then tested for activity.
With this approach, it is possible to insert any small DNA
fragment (carried on a linker) into the randomly cleaved single-
stranded DNA, with the result that a much greater number of
modified genes maybe generated than by error-prone PCR.
The mutations that are developed by this procedure may be used
to select protein variants with a wide range of activities.
E. DNA Shuffling
DNA shuffling is a method for in vitro
recombination of homologous genes
invented byW.P.C Stemmer.
It is done in the hope that some of the
hybrid proteins will have unique properties
or activities that were not encoded in any of
the original sequences.
Also, some of the hybrid proteins may
combine important attributes of two or
more of the original proteins, e.g., high
activity and thermostability.
The genes to be recombined
are randomly fragmented by
DNaseI, and fragments of the
desired size are purified from
an agarose gel.
These fragments are then
reassembled using cycles of
denaturation, annealing, and
extension by a polymerase.
Recombination occurs when
fragments from different
parents anneal at a region of
high sequence identity.
Following this reassembly
reaction, PCR amplification
with primers is used to
generate full-length chimeras
suitable for cloning into an
expression vector.
https://link.springer.com/protocol/10.1385/1-59259-395-X:85
The simplest way to shuffle
portions
through
of similar genes is
the use of common
restriction enzyme sites.
Digestion of two or more of the
DNAs that encode the native
forms of similar proteins with one
or more restriction enzymes that
cut the DNAs in the same place,
followed by ligation of the
mixture of DNA fragments, can
potentially generate a large
number of hybrids.
Another wayto shuffle DNAinvolves
 Combining several members of a gene family
,
fragmenting the mixed DNA with
deoxyribonuclease I (DNase I), selecting smaller
DNA fragments
 Followed by PCR amplifying these fragments.
 During PCR, gene fragments from different
members of a gene family cross-prime each other
after DNA fragments bind to one another in
regions of highhomology/complementarity.
• The final full-length products are obtained by including “terminal primers” in the PCR.
After 20 to 30 PCR cycles,a panel of hybrid (full-length) DNAs willbe established.
• The hybrid DNAs are then used to create a library that can be screened for the desired
activity.
Although DNA shuffling works well with gene families—it is
sometimes called molecular breeding—or with genes from
different families that nevertheless have a high degree of
homology, the technique is not especially useful when proteins
have little or no homology.
Thus, the DNAs must be very similar to one another or the PCR
willnot proceed.
To remedy this situation and combine the genes of dissimilar
proteins, several variations of the DNA-shuffling protocol have
been developed.
(shown in
Different
different
together,
DNAs
colors)
partially
are mixed
digested with
DNase I, blunt ended by digestion
with T4 DNA polymerase.
They are then size fractionated.
The fragments are ligated with
synthetic hairpin DNAs to form
extended hairpins.
Restriction
remove the
generate sticky ends, and
enzymes digest and
hairpin ends and
then
ligated into plasmid vectors.
F.Mutant Proteins with Unusual Amino Acids
Any protein can be altered by substituting one amino acid for
another using directed mutagenesis.
There are only 20 amino acids that are normally used in protein
synthesis, hence this becomes a limitation in generating mutants
One way to increase the diversity of the proteins formed after
mutagenesis is to introduce synthetic amino acids with unique side
chains at specific sites. To do this, E. coli was engineered to produce
both a novel transfer RNA (tRNA) that is not recognized by any of
the existing E. coli aminoacyl-tRNA synthetases but nevertheless
functions in translation and a new aminoacyltRNA synthetase that
aminoacylates only that novel tRNA.
Schematic representation of the production of a protein with a modified
(nonstandard amino acid) side chain. The start codon is highlighted in
green, and the stop codons are in red. The inserted amino acid analogue is
shown in blue.

Weitere ähnliche Inhalte

Was ist angesagt?

Protein sequencing presentation
Protein sequencing presentationProtein sequencing presentation
Protein sequencing presentation
Mobin Aslam
 
CDNA Library preparation. ppt for Jamil sir
CDNA Library preparation. ppt for Jamil sirCDNA Library preparation. ppt for Jamil sir
CDNA Library preparation. ppt for Jamil sir
Nushrat Jahan
 
Histone Modification: Acetylation n Methylation
Histone Modification: Acetylation n MethylationHistone Modification: Acetylation n Methylation
Histone Modification: Acetylation n Methylation
Somanna AN
 
Chapter8 igenetics
Chapter8 igeneticsChapter8 igenetics
Chapter8 igenetics
minhdaovan
 

Was ist angesagt? (20)

Dna replication
Dna replicationDna replication
Dna replication
 
construction of genomicc dna libraries
construction of genomicc dna librariesconstruction of genomicc dna libraries
construction of genomicc dna libraries
 
Degenerate primers
Degenerate primersDegenerate primers
Degenerate primers
 
Molecular Cloning.pptx
Molecular Cloning.pptxMolecular Cloning.pptx
Molecular Cloning.pptx
 
Protein sequencing presentation
Protein sequencing presentationProtein sequencing presentation
Protein sequencing presentation
 
CDNA Library preparation. ppt for Jamil sir
CDNA Library preparation. ppt for Jamil sirCDNA Library preparation. ppt for Jamil sir
CDNA Library preparation. ppt for Jamil sir
 
Molecular cloning vectors
Molecular cloning vectorsMolecular cloning vectors
Molecular cloning vectors
 
Histone Modification: Acetylation n Methylation
Histone Modification: Acetylation n MethylationHistone Modification: Acetylation n Methylation
Histone Modification: Acetylation n Methylation
 
Primerdesign
PrimerdesignPrimerdesign
Primerdesign
 
Dna sequencing
Dna sequencingDna sequencing
Dna sequencing
 
Dna repair systems
Dna repair systemsDna repair systems
Dna repair systems
 
Site-Directed-Mutagenesis.pptx
Site-Directed-Mutagenesis.pptxSite-Directed-Mutagenesis.pptx
Site-Directed-Mutagenesis.pptx
 
PAM : Point Accepted Mutation
PAM : Point Accepted MutationPAM : Point Accepted Mutation
PAM : Point Accepted Mutation
 
Chapter8 igenetics
Chapter8 igeneticsChapter8 igenetics
Chapter8 igenetics
 
Post transcriptional modification ( splicing mechanisms)
Post transcriptional modification ( splicing mechanisms)Post transcriptional modification ( splicing mechanisms)
Post transcriptional modification ( splicing mechanisms)
 
Protein Folding
Protein Folding Protein Folding
Protein Folding
 
Presentation1
Presentation1Presentation1
Presentation1
 
Types of PCR
Types of PCR Types of PCR
Types of PCR
 
Pcr primer design
Pcr primer designPcr primer design
Pcr primer design
 
Eukaryotic regulation
Eukaryotic regulationEukaryotic regulation
Eukaryotic regulation
 

Ähnlich wie Site Directed Mutagenesis (SDM).pptx

Site Directed mutagenesis- Sonal Singh Shrivas.pptx
Site Directed mutagenesis- Sonal Singh Shrivas.pptxSite Directed mutagenesis- Sonal Singh Shrivas.pptx
Site Directed mutagenesis- Sonal Singh Shrivas.pptx
SonalShrivas
 
Dr waheed presentation (1)
Dr waheed presentation (1)Dr waheed presentation (1)
Dr waheed presentation (1)
Zahid Hussain
 

Ähnlich wie Site Directed Mutagenesis (SDM).pptx (20)

Site Directed Mutagenesis.pdf
Site Directed Mutagenesis.pdfSite Directed Mutagenesis.pdf
Site Directed Mutagenesis.pdf
 
BMB 422 site directed mutag.-1.ppt
BMB 422 site directed mutag.-1.pptBMB 422 site directed mutag.-1.ppt
BMB 422 site directed mutag.-1.ppt
 
Site directed mutgenesis, OLIGONUCLEOTIDE DIRECTED MUTAGENESIS
Site directed mutgenesis, OLIGONUCLEOTIDE DIRECTED MUTAGENESIS Site directed mutgenesis, OLIGONUCLEOTIDE DIRECTED MUTAGENESIS
Site directed mutgenesis, OLIGONUCLEOTIDE DIRECTED MUTAGENESIS
 
Protein engineering
Protein engineeringProtein engineering
Protein engineering
 
Protein engineering
Protein engineeringProtein engineering
Protein engineering
 
Site directed mutagenesis
Site directed mutagenesisSite directed mutagenesis
Site directed mutagenesis
 
Site Directed mutagenesis- Sonal Singh Shrivas.pptx
Site Directed mutagenesis- Sonal Singh Shrivas.pptxSite Directed mutagenesis- Sonal Singh Shrivas.pptx
Site Directed mutagenesis- Sonal Singh Shrivas.pptx
 
zahid hussain ajk
zahid hussain ajkzahid hussain ajk
zahid hussain ajk
 
SITE-DIRECTED MUTAGENESIS.pptx
SITE-DIRECTED MUTAGENESIS.pptxSITE-DIRECTED MUTAGENESIS.pptx
SITE-DIRECTED MUTAGENESIS.pptx
 
recombinant DNA with subtopics
recombinant DNA with subtopicsrecombinant DNA with subtopics
recombinant DNA with subtopics
 
Site directed mutagenesis
Site  directed mutagenesisSite  directed mutagenesis
Site directed mutagenesis
 
OLIGONUCLEOTIDE THERAPY [ TECHNIQUES, APPLICATIONS]
OLIGONUCLEOTIDE THERAPY [ TECHNIQUES, APPLICATIONS]OLIGONUCLEOTIDE THERAPY [ TECHNIQUES, APPLICATIONS]
OLIGONUCLEOTIDE THERAPY [ TECHNIQUES, APPLICATIONS]
 
Lectut btn-202-ppt-l29. applications of pcr-i (1)
Lectut btn-202-ppt-l29. applications of pcr-i (1)Lectut btn-202-ppt-l29. applications of pcr-i (1)
Lectut btn-202-ppt-l29. applications of pcr-i (1)
 
Dr waheed presentation (1)
Dr waheed presentation (1)Dr waheed presentation (1)
Dr waheed presentation (1)
 
TILLING and Eco-TILLING for crop improvement
TILLING and Eco-TILLING for crop improvementTILLING and Eco-TILLING for crop improvement
TILLING and Eco-TILLING for crop improvement
 
DNA Repair
DNA Repair DNA Repair
DNA Repair
 
Protein Engineering - Ashvini.pptx
Protein Engineering - Ashvini.pptxProtein Engineering - Ashvini.pptx
Protein Engineering - Ashvini.pptx
 
Gene isolation methods
Gene isolation methodsGene isolation methods
Gene isolation methods
 
Gene sequencing methods
Gene sequencing methodsGene sequencing methods
Gene sequencing methods
 
Hybrdization
HybrdizationHybrdization
Hybrdization
 

Kürzlich hochgeladen

Artificial Intelligence: Facts and Myths
Artificial Intelligence: Facts and MythsArtificial Intelligence: Facts and Myths
Artificial Intelligence: Facts and Myths
Joaquim Jorge
 

Kürzlich hochgeladen (20)

Automating Google Workspace (GWS) & more with Apps Script
Automating Google Workspace (GWS) & more with Apps ScriptAutomating Google Workspace (GWS) & more with Apps Script
Automating Google Workspace (GWS) & more with Apps Script
 
Powerful Google developer tools for immediate impact! (2023-24 C)
Powerful Google developer tools for immediate impact! (2023-24 C)Powerful Google developer tools for immediate impact! (2023-24 C)
Powerful Google developer tools for immediate impact! (2023-24 C)
 
Partners Life - Insurer Innovation Award 2024
Partners Life - Insurer Innovation Award 2024Partners Life - Insurer Innovation Award 2024
Partners Life - Insurer Innovation Award 2024
 
Axa Assurance Maroc - Insurer Innovation Award 2024
Axa Assurance Maroc - Insurer Innovation Award 2024Axa Assurance Maroc - Insurer Innovation Award 2024
Axa Assurance Maroc - Insurer Innovation Award 2024
 
How to Troubleshoot Apps for the Modern Connected Worker
How to Troubleshoot Apps for the Modern Connected WorkerHow to Troubleshoot Apps for the Modern Connected Worker
How to Troubleshoot Apps for the Modern Connected Worker
 
From Event to Action: Accelerate Your Decision Making with Real-Time Automation
From Event to Action: Accelerate Your Decision Making with Real-Time AutomationFrom Event to Action: Accelerate Your Decision Making with Real-Time Automation
From Event to Action: Accelerate Your Decision Making with Real-Time Automation
 
[2024]Digital Global Overview Report 2024 Meltwater.pdf
[2024]Digital Global Overview Report 2024 Meltwater.pdf[2024]Digital Global Overview Report 2024 Meltwater.pdf
[2024]Digital Global Overview Report 2024 Meltwater.pdf
 
Exploring the Future Potential of AI-Enabled Smartphone Processors
Exploring the Future Potential of AI-Enabled Smartphone ProcessorsExploring the Future Potential of AI-Enabled Smartphone Processors
Exploring the Future Potential of AI-Enabled Smartphone Processors
 
presentation ICT roal in 21st century education
presentation ICT roal in 21st century educationpresentation ICT roal in 21st century education
presentation ICT roal in 21st century education
 
Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...
Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...
Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...
 
08448380779 Call Girls In Diplomatic Enclave Women Seeking Men
08448380779 Call Girls In Diplomatic Enclave Women Seeking Men08448380779 Call Girls In Diplomatic Enclave Women Seeking Men
08448380779 Call Girls In Diplomatic Enclave Women Seeking Men
 
A Domino Admins Adventures (Engage 2024)
A Domino Admins Adventures (Engage 2024)A Domino Admins Adventures (Engage 2024)
A Domino Admins Adventures (Engage 2024)
 
Handwritten Text Recognition for manuscripts and early printed texts
Handwritten Text Recognition for manuscripts and early printed textsHandwritten Text Recognition for manuscripts and early printed texts
Handwritten Text Recognition for manuscripts and early printed texts
 
Tech Trends Report 2024 Future Today Institute.pdf
Tech Trends Report 2024 Future Today Institute.pdfTech Trends Report 2024 Future Today Institute.pdf
Tech Trends Report 2024 Future Today Institute.pdf
 
Presentation on how to chat with PDF using ChatGPT code interpreter
Presentation on how to chat with PDF using ChatGPT code interpreterPresentation on how to chat with PDF using ChatGPT code interpreter
Presentation on how to chat with PDF using ChatGPT code interpreter
 
GenCyber Cyber Security Day Presentation
GenCyber Cyber Security Day PresentationGenCyber Cyber Security Day Presentation
GenCyber Cyber Security Day Presentation
 
Scaling API-first – The story of a global engineering organization
Scaling API-first – The story of a global engineering organizationScaling API-first – The story of a global engineering organization
Scaling API-first – The story of a global engineering organization
 
Artificial Intelligence: Facts and Myths
Artificial Intelligence: Facts and MythsArtificial Intelligence: Facts and Myths
Artificial Intelligence: Facts and Myths
 
How to Troubleshoot Apps for the Modern Connected Worker
How to Troubleshoot Apps for the Modern Connected WorkerHow to Troubleshoot Apps for the Modern Connected Worker
How to Troubleshoot Apps for the Modern Connected Worker
 
Raspberry Pi 5: Challenges and Solutions in Bringing up an OpenGL/Vulkan Driv...
Raspberry Pi 5: Challenges and Solutions in Bringing up an OpenGL/Vulkan Driv...Raspberry Pi 5: Challenges and Solutions in Bringing up an OpenGL/Vulkan Driv...
Raspberry Pi 5: Challenges and Solutions in Bringing up an OpenGL/Vulkan Driv...
 

Site Directed Mutagenesis (SDM).pptx

  • 1. UNIT IX PART A Site-directed Mutagenesis (SDM) GEB, Sem VI, B.Sc (H) Biochemistry Dr. Jayita Thakur
  • 2. Michael Smith, a British-born Canadian biochemist won the 1993 Nobel Prize (with Kary B. Mullis) in Chemistry for the development of a technique called - oligonucleotide-based site-directed mutagenesis, which enabled researchers to introduce specific mutations into genes and, thus, to the proteins that they encode.
  • 3. Site-directed mutagenesis (SDM) is a method to create specific, targeted changes in double stranded plasmid DNA. There are many reasons to make specific DNA alterations (insertions, deletions and substitutions), including: • To study changes in protein activity that occur as a result of the DNA manipulation. • To select or screen for mutations (at the DNA, RNA or protein level) that have a desired property. • To introduce or remove restriction endonuclease sites or tags.
  • 4. Using site-directed mutagenesis, • scientists have been able to dissect the structure and function relationships involved in protein plaque formation in the pathophysiology of Alzheimer disease; • study the feasibility of gene therapy approaches for cystic fibrosis, sickle-cell disease, and hemophilia; • determine the characteristics of protein receptors at neurotransmitter binding sites and design analogs with novel pharmaceutical properties; • examine the viral proteins involved in immunodeficiency disease; • and improve the properties of industrial enzymes used in food science and technology.
  • 5. STRATEGIES OF DIRECTED MUTAGENESIS A. Oligonucleotide-Directed Mutagenesis with M13 DNA B. Oligonucleotide-Directed Mutagenesis with Plasmid DNA C. PCR based mutagenesis i. PCR-Amplified Oligonucleotide-Directed Mutagenesis ii. Error-Prone PCR iii. Random Mutagenesis with Degenerate Oligonucleotide Primers D. Random Insertion/Deletion Mutagenesis E. DNA Shuffling F. Mutant Proteins with Unusual Amino Acids
  • 7. Single-stranded bacteriophage M13 (M13 + strand), carrying a cloned gene is taken. It is annealed with a complementary synthetic oligonucleotide containing one mismatched base. With the oligonucleotide as the primer, DNA synthesis is catalyzed by the Klenow fragment of E. coliDNA polymerase I. Synthesis continues until the entire strand is copied. The newly synthesized DNA strand is circularized byT4 DNA ligase. The ligation reaction mixture is used to transform E. coli. Both the target DNA with its original sequence and the mutated sequence are present in the progeny M13 phage. After the double-stranded form of M13 is isolated, the mutated gene is excised by digestion with restriction enzymes and then spliced onto an E. coliplasmid expression vector. For further study, the altered protein is expressed in and purified from the E. colicells.
  • 8.
  • 9.
  • 10. As per the diagram we see only 50% of the M13 viruses are expected to carrying the mutated form of thetarget. In practice only around 1% of the plaques actually contain phage carrying the mutated gene. Consequently, the oligonucleotide-directed mutagenesis method has been modified in several ways to enrich for the number of mutant phage plaques that can be obtained.
  • 11. Modification Introduce the M13 viral vector carrying the gene that is to be mutagenized into an E. coli strain that has two defective enzymes of DNAmetabolism.
  • 12. dUTPase (dut) Cells without a dUTPase have an functional elevated intracellular level of dUTP , which in turn causes a few incorporated into dUTP residues to be DNA during replication instead of dTTP. uracil N-glycosylase (ung) In the absence of functional uracil N-glycosylase, the dUTP residues that were spuriously incorporated into DNA cannot be removed.
  • 13. The target DNA is cloned into the double-stranded replicative form of bacteriophage M13, which is then used to transform a dut ung strain of E. coli. The dut mutation causes the intracellular level of dUTP to be elevated; the high level of nucleotide leads to the incorporation of a few dUTP residues (U). The ung mutation prevents the removal of any incorporated uracil residues. Following in vitro oligonucleotide-directed mutagenesis, the double- stranded M13 vector with the mutated DNA is introduced into wild-type E. coli. The wild-type ung gene product removes any uracil residues from the parental strand, so a significant portion of the parental strand is degraded. The mutated strand remains intact because it does not contain uracil. It serves as a template for DNA replication, thereby enriching the yield of M13 bacteriophage carrying the mutated gene.
  • 14. Drawbacks of using the M13DNA for carrying out SDM • There is a need to subclone a target gene from a plasmid into M13 and then, after mutagenesis, clone it back into a plasmid. • Additional step of transforming enzyme defective E. coli necessary to enrich the yield. • Lengthy process involving multiple steps
  • 16. Thetarget DNAis inserted into the multiple cloning site (MCS)on the vector pALTER. Plasmid DNAis isolated from E. coli cells and alkalinedenatured. Mutagenic resistance tetracycline annealed. oligonucleotide, the (Ampr) oligonucleotide, ampicillin and the sensitivity (Tets)oligonucleotide are The oligonucleotides act as primers for DNA synthesis by T4 DNA polymerase with the original strand asthe template. The gaps between the synthesized pieces of DNA are sealed by T4DNAligase. The reaction mixture is used to transform E. coli host cells, and cells that are Ampr and Tets are selected.
  • 17. • With this procedure, about 90% of the selected transformants have the specified mutation in the target gene. • In the remaining transformants, the target gene is unchanged because the oligonucleotide did not anneal to the target gene or it was bypassed during DNA synthesis. • The cells with the specified mutation in the target gene are identified by DNA hybridization. • All of the plasmids, host bacterial strains, enzymes, oligonucleotides (other than the one needed to alter the target gene), and buffers for this method are sold as a kit, facilitating its widespread use.
  • 18. C. PCR based mutagenesis
  • 20. • For this method of mutagenesis, no special plasmid vectors are required; any plasmid up to approximately 10 kb in length is acceptable. • For PCR-based mutagenesis point mutations, nucleotide changes are introduced in the middle of the primer sequence. • To create deletion mutations, primers must border the region of target DNA to be deleted on both sides and be perfectly matched to their annealing (or template) sequences. • To create mutations with long insertions, a stretch of mismatched nucleotides is added to the 5′ end of one or both primers, while for mutations with short insertions, a stretch of nucleotides is designed in the middle of one of the primers.
  • 21. Overview of the basic methodology to introduce point mutations, insertions, or deletions into DNAcloned into aplasmid.
  • 22. In all of these procedures, the only absolute requirementsare that: (1)the nucleotide sequence of the target DNA must be known. (2)the 5′ends of the primers must be phosphorylated. Following PCR amplification, the linear DNA is circularized by ligation with T4 DNA ligase. The circularized plasmid DNA is then used to transform E. coli by any standard procedure. This protocol yields a very high frequency of plasmids with the desired mutation. The screening three or four clones by sequencing the target DNA should be sufficient to find the desired
  • 23. In summary, this procedure introduces a specified mutation (point, insertion, or deletion) into a cloned gene without the need to insert the cloned gene into bacteriophage M13; to use enrichment procedures, such as the dut ung system; or to subclone the mutated gene from M13 onto an expression plasmid vector. Given its simplicity and effectiveness, this procedure has come to be widely used.
  • 25. This is a very powerful method for random mutagenesis useful for the construction of a library of mutants. With DNA up to 10 kb in size, it is possible to vary the number of alterations per gene from about 1 to about 20 by modifying the DNA template concentration. When error-prone PCR is performed using Taq DNA polymerase, which lacks proofreading activity, the error rate may be increased- A. by adding Mn2+, by increasing the concentration of Mg2+ B. by adding unequal amounts of the four deoxynucleoside triphosphates to the reaction buffer. C. by using other temperature-stable DNA polymerases in the absence of Mn2+ and with balanced amounts of the four deoxynucleoside triphosphates.
  • 26.
  • 27. • Following error-prone PCR, the randomly mutagenized DNA is cloned into expression vectors and screened for altered or improved protein activity. • The DNA from those clones that encode the desired activity is isolated and sequenced so that the relevant changes to the target DNA may be elaborated. • Error-prone PCR has been used to create enzymes with improved solvent and temperature stability and with enhanced specific activity.
  • 28. Drawback Since errors are typically introduced into DNA at no more than one or two per 1,000 nucleotides, only single nucleotides are replaced within a triplet codon, yielding only a limited number of amino acid changes.
  • 29. C. (iii) Random Mutagenesis with Degenerate Oligonucleotide Primers
  • 30. Investigators seldom know which specific nucleotide changes need to be introduced into a cloned gene to modify the properties of the targetprotein. Consequently, they must use methods that generate all the possible amino acid changes at one particular site. For example, oligonucleotide primers can be synthesized with any of the four nucleotides at defined positions. This pattern of sequence degeneracy is generally achieved by programming an automated DNA synthesis reaction to add a low level (usually a few percent) of each of the three alternative nucleotides each time a particular nucleotide is added to the chain.
  • 31. In this way, the oligonucleotide primer preparation contains a heterogeneous set of DNA sequences that will generate a series of mutations that are clustered in a defined portion of the target gene.
  • 32. A target gene is inserted into a plasmid between two unique restriction endonuclease sites. The left and right portions of the target DNA are amplified separately by PCR. The amplified fragments are purified, denatured to make them single stranded, and then reannealed. Complementary regions of overlap are formed between complementary producing oligonucleotides. The mutation single- stranded regions are made double stranded with DNA polymerase, and then the entire fragment is amplified by PCR. The resultant product is digested with restriction endonucleases A and B and then cloned into a vector that has been digested with the same enzymes. A mutation producing oligonucleotide is shown as a line with three spikes; each spike denotes a position that contains a nucleotide that is not found in the native gene.
  • 33. This approach has two advantages. (1) Detailed information regarding the roles of particular amino acid residues in the functioning of the protein is not required. (2) Unexpected mutants encoding proteins with a range of interesting and useful properties may be generated because the introduced changes are not limited to one amino acid.
  • 35. As an alternative to error-prone PCR, researchers have developed the technique of random insertion/deletion mutagenesis. With this approach, it is possible to delete a small number of nucleotides at random positions along the gene and, at the same time, insert either specific or random sequences into that position.
  • 36.
  • 37. 1. An isolated gene fragment with different restriction endonuclease sites at each end is ligated at one end to a short nonphosphorylated linker that leaves a small gap in the DNA. The gap is a consequence of the fact that the 5′ nucleotide from the linker is not phosphorylated and therefore cannot be ligated to an adjacent 3′-OHgroup. 2. After restriction enzyme digestion that creates compatible sticky ends, the gene fragment is cyclized with T4 DNA ligase to create a circular double-stranded gene fragment with a nick in the antisense strand. 3. The nicked strand is degraded by digestion with the enzyme T4 DNA polymerase (which hasexonuclease activity). 4. The single-stranded DNA is randomly cleaved at single positions by treating it with a cerium(IV)–ethylenediaminetetraacetic acid (EDTA) complex.
  • 38. 5.The linear single-stranded DNAs are ligated to a linker (containing several additional nucleotides selected for insertion at one end), and the entire mutagenesis library is PCRamplified. 6. Thelinkers are removed by restriction enzyme digestion. 7.The constructs are made blunt ended by filling in the single stranded overhangs using the Klenow fragment of E. coli DNApolymerase I and then cyclized again by T4DNAligase. 8.Theamplified products are digested with appropriate restriction enzymes, cloned into aplasmid vector, and then tested for activity.
  • 39. With this approach, it is possible to insert any small DNA fragment (carried on a linker) into the randomly cleaved single- stranded DNA, with the result that a much greater number of modified genes maybe generated than by error-prone PCR. The mutations that are developed by this procedure may be used to select protein variants with a wide range of activities.
  • 41. DNA shuffling is a method for in vitro recombination of homologous genes invented byW.P.C Stemmer. It is done in the hope that some of the hybrid proteins will have unique properties or activities that were not encoded in any of the original sequences. Also, some of the hybrid proteins may combine important attributes of two or more of the original proteins, e.g., high activity and thermostability.
  • 42. The genes to be recombined are randomly fragmented by DNaseI, and fragments of the desired size are purified from an agarose gel. These fragments are then reassembled using cycles of denaturation, annealing, and extension by a polymerase. Recombination occurs when fragments from different parents anneal at a region of high sequence identity. Following this reassembly reaction, PCR amplification with primers is used to generate full-length chimeras suitable for cloning into an expression vector. https://link.springer.com/protocol/10.1385/1-59259-395-X:85
  • 43. The simplest way to shuffle portions through of similar genes is the use of common restriction enzyme sites. Digestion of two or more of the DNAs that encode the native forms of similar proteins with one or more restriction enzymes that cut the DNAs in the same place, followed by ligation of the mixture of DNA fragments, can potentially generate a large number of hybrids.
  • 44. Another wayto shuffle DNAinvolves  Combining several members of a gene family , fragmenting the mixed DNA with deoxyribonuclease I (DNase I), selecting smaller DNA fragments  Followed by PCR amplifying these fragments.  During PCR, gene fragments from different members of a gene family cross-prime each other after DNA fragments bind to one another in regions of highhomology/complementarity. • The final full-length products are obtained by including “terminal primers” in the PCR. After 20 to 30 PCR cycles,a panel of hybrid (full-length) DNAs willbe established. • The hybrid DNAs are then used to create a library that can be screened for the desired activity.
  • 45. Although DNA shuffling works well with gene families—it is sometimes called molecular breeding—or with genes from different families that nevertheless have a high degree of homology, the technique is not especially useful when proteins have little or no homology. Thus, the DNAs must be very similar to one another or the PCR willnot proceed. To remedy this situation and combine the genes of dissimilar proteins, several variations of the DNA-shuffling protocol have been developed.
  • 46. (shown in Different different together, DNAs colors) partially are mixed digested with DNase I, blunt ended by digestion with T4 DNA polymerase. They are then size fractionated. The fragments are ligated with synthetic hairpin DNAs to form extended hairpins. Restriction remove the generate sticky ends, and enzymes digest and hairpin ends and then ligated into plasmid vectors.
  • 47. F.Mutant Proteins with Unusual Amino Acids
  • 48. Any protein can be altered by substituting one amino acid for another using directed mutagenesis. There are only 20 amino acids that are normally used in protein synthesis, hence this becomes a limitation in generating mutants One way to increase the diversity of the proteins formed after mutagenesis is to introduce synthetic amino acids with unique side chains at specific sites. To do this, E. coli was engineered to produce both a novel transfer RNA (tRNA) that is not recognized by any of the existing E. coli aminoacyl-tRNA synthetases but nevertheless functions in translation and a new aminoacyltRNA synthetase that aminoacylates only that novel tRNA.
  • 49. Schematic representation of the production of a protein with a modified (nonstandard amino acid) side chain. The start codon is highlighted in green, and the stop codons are in red. The inserted amino acid analogue is shown in blue.